JP2014513141A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014513141A5 JP2014513141A5 JP2014509519A JP2014509519A JP2014513141A5 JP 2014513141 A5 JP2014513141 A5 JP 2014513141A5 JP 2014509519 A JP2014509519 A JP 2014509519A JP 2014509519 A JP2014509519 A JP 2014509519A JP 2014513141 A5 JP2014513141 A5 JP 2014513141A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- hydrogen
- subject
- compound
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161483630P | 2011-05-06 | 2011-05-06 | |
| US61/483,630 | 2011-05-06 | ||
| PCT/US2012/036841 WO2012154695A2 (en) | 2011-05-06 | 2012-05-07 | Treatment of polycystic disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014513141A JP2014513141A (ja) | 2014-05-29 |
| JP2014513141A5 true JP2014513141A5 (enExample) | 2015-09-10 |
| JP6122420B2 JP6122420B2 (ja) | 2017-04-26 |
Family
ID=47139933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014509519A Active JP6122420B2 (ja) | 2011-05-06 | 2012-05-07 | 多発性嚢胞疾患の治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20140066462A1 (enExample) |
| EP (1) | EP2704723A4 (enExample) |
| JP (1) | JP6122420B2 (enExample) |
| CN (1) | CN103796655A (enExample) |
| CA (1) | CA2835197A1 (enExample) |
| WO (1) | WO2012154695A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1831225A2 (en) | 2004-11-19 | 2007-09-12 | The Regents of the University of California | Anti-inflammatory pyrazolopyrimidines |
| WO2010006072A2 (en) | 2008-07-08 | 2010-01-14 | The Regents Of The University Of California | Mtor modulators and uses thereof |
| WO2016040806A1 (en) * | 2014-09-11 | 2016-03-17 | The Regents Of The University Of California | mTORC1 INHIBITORS |
| WO2016057931A1 (en) | 2014-10-10 | 2016-04-14 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
| AU2016342027B2 (en) * | 2015-10-23 | 2021-05-13 | Navitor Pharmaceuticals, Inc. | Modulators of Sestrin-GATOR2 interaction and uses thereof |
| US10623555B2 (en) | 2016-09-27 | 2020-04-14 | Hartford Fire Insurance Company | Controlling a graphical user interface for workflow |
| FR3075794A1 (fr) | 2017-12-21 | 2019-06-28 | Galderma Research & Development | Nouveaux composes inhibiteurs de mtor |
| FR3075795A1 (fr) | 2017-12-21 | 2019-06-28 | Galderma Research & Development | Nouveaux composes inhibiteurs de mtor |
| CA3098698A1 (en) | 2018-05-01 | 2019-11-07 | Revolution Medicines, Inc. | C26-linked rapamycin analogs as mtor inhibitors |
| CN118978535A (zh) | 2018-05-01 | 2024-11-19 | 锐新医药公司 | 作为mTOR抑制剂的C40-、C28-及C-32连接的雷帕霉素类似物 |
| JP2025522296A (ja) | 2022-05-25 | 2025-07-15 | レヴォリューション・メディスンズ，インコーポレイテッド | ｍＴＯＲ阻害剤によりがんを処置する方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0523659D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| AU2009268611B2 (en) * | 2008-07-08 | 2015-04-09 | Intellikine, Llc | Kinase inhibitors and methods of use |
| US8476282B2 (en) * | 2008-11-03 | 2013-07-02 | Intellikine Llc | Benzoxazole kinase inhibitors and methods of use |
| MY162604A (en) * | 2009-08-17 | 2017-06-30 | Intellikine Llc | Heterocyclic compounds and uses thereof |
| ES2618489T3 (es) * | 2011-05-04 | 2017-06-21 | Intellikine, Llc | Composiciones farmacéuticas combinadas y usos de las mismas |
-
2012
- 2012-05-07 CN CN201280033519.9A patent/CN103796655A/zh active Pending
- 2012-05-07 JP JP2014509519A patent/JP6122420B2/ja active Active
- 2012-05-07 WO PCT/US2012/036841 patent/WO2012154695A2/en not_active Ceased
- 2012-05-07 CA CA 2835197 patent/CA2835197A1/en not_active Abandoned
- 2012-05-07 EP EP12782025.6A patent/EP2704723A4/en not_active Withdrawn
-
2013
- 2013-11-06 US US14/073,090 patent/US20140066462A1/en not_active Abandoned